Alzheimer's Drug Discovery Foundation (ADDF)
The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
مقدمة مفصلة
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
المزيدالبحث
JSTOR
JSTOR is a digital library providing access to a vast collection of academic journals, books, and primary sources across various disciplines, facilitating research and education worldwide.
iScience Group at University of Konstanz
The iScience group at the University of Konstanz focuses on methodologies for Internet-based scientific research and the interplay of Internet and Psychology.
The International OCD Foundation | OCD Support and Resources
The International OCD Foundation is dedicated to providing support and resources for individuals with OCD and related disorders. It offers a range of programs, including an online OCD camp, educational webinars, and a resource directory to find help. The foundation also funds research to advance the understanding and treatment of OCD.